Literature DB >> 14975209

Effect of human osteopontin on proliferation, transmigration and expression of MMP-2 and MMP-9 in osteosarcoma cells.

Si-jin Liu1, Guo-fa Hu, Ya-jun Liu, Si-Guo Liu, Hong Gao, Chuan-sheng Zhang, Ying-yun Wei, Yan Xue, Wei-de Lao.   

Abstract

BACKGROUND: To explore the effect of human osteopontin (hOPN) on the proliferation, transmigration and expression of matrix metallproteinase-2 (MMP-2) and matrix metallproteinase-9 (MMP-9) in osteosarcoma (OS) cells in vitro.
METHODS: The prokaryotic-expression vector of hOPN was produced. hOPN was then subcloned into E. coli BL21 (DE3) cells and purified with ProBond trade mark Columns. The proliferation, cell cycle and the expression of cyclin A in OS cells were investigated by using MTT assay, flow cytometry and Western blot respectively. The transmigration of OS cells was checked by using transwell cell culture chamber. The micro-pore-filter-membrane system was used to study the chemiotaxis of hOPN to OS cells. The levels of total protein were examined according to Coomassie Brilliant Blue manuals. The expression of MMP-2 and MMP-9 were evaluated by detecting the volume of degradation of gelatin on SDS-PAGE gel.
RESULTS: The prokaryotic-expression vector of hOPN and purified hOPN protein were achieved hOPN promoted OS cells proliferation in a dose-dependent manner, and stimulated cyclin A expression in OS cells to accelerate cell division cycle. hOPN facilitated the trans-membrane migration of OS cells. hOPN also enhanced the secretion of MMP-2 and MMP-9 in OS cells.
CONCLUSION: hOPN could stimulate cyclin A expression in OS cells. hOPN has chemiotaxis to OS cells and increases their transmigration. hOPN enhances the secretion of MMP-2 and MMP-9 in OS cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14975209

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  9 in total

1.  The elevated expression of osteopontin and NF-κB in human aortic aneurysms and its implication.

Authors:  Tao Mi; Bin Nie; Cuntai Zhang; Honglian Zhou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-10-25

Review 2.  Role of osteopontin in osteosarcoma.

Authors:  Yu-Sheng Li; Zhen-Han Deng; Chao Zeng; Guang-Hua Lei
Journal:  Med Oncol       Date:  2014-12-17       Impact factor: 3.064

3.  Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies.

Authors:  Si-Jin Liu; Zi-Wei Cai; Ya-Jun Liu; Mei-Yu Dong; Li-Qiu Sun; Guo-Fa Hu; Ying-Yun Wei; Wei-De Lao
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

4.  Regulation of osteosarcoma cell invasion through osteopontin modification by miR-4262.

Authors:  Kun Song; Ning Liu; Yan Yang; Xue Qiu
Journal:  Tumour Biol       Date:  2015-12-03

Review 5.  Osteopontin as a biomarker for osteosarcoma therapy and prognosis.

Authors:  Xingwen Han; Wenji Wang; Jingjing He; Lei Jiang; Xun Li
Journal:  Oncol Lett       Date:  2019-01-08       Impact factor: 2.967

6.  Loss of MMP-2 in murine osteoblasts upregulates osteopontin and bone sialoprotein expression in a circuit regulating bone homeostasis.

Authors:  Rebecca A Mosig; John A Martignetti
Journal:  Dis Model Mech       Date:  2012-08-23       Impact factor: 5.758

7.  Osteopontin expression in reactive lesions of gingiva.

Authors:  Rathinam Elanagai; Veeran Veeravarmal; Ramdas Madhavan Nirmal
Journal:  J Appl Oral Sci       Date:  2015 Jan-Feb       Impact factor: 2.698

8.  Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression.

Authors:  Hsin-Lin Cheng; Ming-Ju Hsieh; Jia-Sin Yang; Chiao-Wen Lin; Ko-Haung Lue; Ko-Hsiu Lu; Shun-Fa Yang
Journal:  Oncotarget       Date:  2016-06-07

9.  Osteopontin expression and clinicopathologic correlation of oral hyperplastic reactive lesions: An institutional 6-year retrospective study.

Authors:  Anjali Narwal; Shashi Bala
Journal:  J Oral Maxillofac Pathol       Date:  2017 Sep-Dec
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.